Biogen drug shows it can delay onset of multiple sclerosis

Article Abstract:

Biogen Inc.'s Avonex drug has proven to be able to prevent the arrival of multiple sclerosis. Avonex is used for the treatment of the disease.

Central Nervous System Prep, Product development, Multiple sclerosis, Central nervous system agents, Biogen Inc., Avonex (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Actelion nears launch of drug after U.S. regulatory action

Article Abstract:

Actelion AG is close to launching its Tracleer pulmonary hypertension drug on the market. Tracleer was given regulatory approval by the U.S. Food and Drug Administration.

Author: Sargent, Carey
Blood Pressure Preparations, Marketing, Hypertension, Antihypertensive agents, Actelion AG, Tracleer (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Agent shows promise for people with Gleevec-resistant tumors

Article Abstract:

Pfizer Inc. has a new drug that has the potential to treat patients who have a rare digestive tract cancer. The drug has shown to be effective in patients who are resistant to the Gleevec drug.

Author: Winslow, Ron
Anticancer Drugs, Chemotherapeutic Drugs, Anticancer Immunostimulant Preps, Pfizer Inc., Antineoplastic agents, PFE, Gleevec (Medication), Antimitotic agents

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment, United States, Pharmaceutical industry, Product information
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.